Patrick Lamy - Jan 10, 2023 Form 3 Insider Report for Akero Therapeutics, Inc. (AKRO)

Role: Exhibit 24: Power of Attorney Senior Vice President, Commercial Strategy
Signature: /s/ Jonathan Young, attorney-in-fact
Stock symbol: AKRO
Transactions as of: Jan 10, 2023
Transactions value $: $0
Form type: 3
Date filed: 1/11/2023, 06:49 PM
Next filing: Dec 12, 2023

No securities are beneficially owned.

Remarks:

Exhibit 24: Power of Attorney Senior Vice President, Commercial Strategy